EviRed uses artificial intelligence to answer a medical need: replacing the current classification of diabetic retinopathy which is mainly based on outdated fundus photography and providing an insufficient prediction precision.
EviRed will use modern fundus imaging devices and artificial intelligence to properly integrate the vast amount of data they provide with other available medical data of the patient. It will then allow an improved diagnosis and prediction, and help ophthalmologists make a better decision during diabetic retinopathy follow-up. It should lead to critical progress in diabetic retinopathy management, a priority cause of blindness even in developed countries.
EviRed project leader,
until 19 April 2024
EviRed project leader
This work benefits from State aid managed by the National Research Agency under the investment program for the Future integrated to France 2030 bearing the reference ANR-18-RHUS-0008
Our latest
News
The Evired team was present at the “Retina and Diabete” organized by Pascale Massin and Catherine Creuzot Garcher
The 4th « Retine and Diabete » congress has been hold in Paris last Friday November 29th The whole day focused on latest developments as well future
MICCAI 2024 – Presence of EviRed team and IA challenges lead by LaTIM team
As in previous years, LaTIM members represented the EVIRED consortium at MICCAI, the premier conference on AI for medical image analysis. Rachid Zeghlache presented his
EviRed team attented the amazing EURETINA congress in Barcelona
EURETINA congress took place in Barcelona this year, september 18th-22nd During the congress – Pr Aude Couturier, Head of Ophthalmology department at Lariboisière Hospital, presented
EviRed website: Release of the Publications’ page
The EviRed website has been completed by a new publication page! On this new page (https://evired.org/publications/), you will find all scientific communications, posters, articles
EviRed team members were present during the ARVO 2024
As in previous years, the entire ophthalmology research community gathered at the ARVO 2024 conference, held in Seattle, USA, from May 4 to May 8,
Thesis defense on “Topology and morphometry of healthy and pathological human retinal capillaries”.
On the 26 April 2024, Dr Sophie Bonnin, defended her PhD thesis brilliantly entitled “Topology and morphometry of healthy and pathological human retinal capillaries “.